HuGE Literature Finder
Records
1
-
5
KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis. JHEP reports (Online) 2019 Nov 1 (5): 353-360. Umemura Takeji, Joshita Satoru, Saito Hiromi, Yoshizawa Kaname, Norman Gary L, Tanaka Eiji, Ota Mas |
HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs. Journal of hepatology 2017 Apr . Thöns Christine, Senff Tina, Hydes Theresa J, Manser Angela R, Heinemann Falko M, Heinold Andreas, Heilmann Martin, Kim Arthur Y, Uhrberg Markus, Scherbaum Norbert, Lauer Georg M, Khakoo Salim I, Timm Jö |
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases. PloS one 2015 10 (2): e0117420. De Re Valli, Caggiari Laura, De Zorzi Mariangela, Repetto Ombretta, Zignego Anna Linda, Izzo Francesco, Tornesello Maria Lina, Buonaguro Franco Maria, Mangia Alessandra, Sansonno Domenico, Racanelli Vito, De Vita Salvatore, Pioltelli Pietro, Vaccher Emanuela, Berretta Massimiliano, Beretta Massimiliano, Mazzaro Cesare, Libra Massimo, Gini Andrea, Zucchetto Antonella, Cannizzaro Renato, De Paoli Pao |
KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C. Human immunology 2014 Aug 75 (8): 822-6. Umemura Takeji, Ota Masao, Katsuyama Yoshihiko, Wada Shuichi, Mori Hiromitsu, Maruyama Atsushi, Shibata Soichiro, Nozawa Yuichi, Kimura Takefumi, Morita Susumu, Joshita Satoru, Komatsu Michiharu, Matsumoto Akihiro, Kamijo Atsushi, Kobayashi Masakazu, Takamatsu Masato, Yoshizawa Kaname, Kiyosawa Kendo, Tanaka Ei |
KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan. PloS one 2013 8 (12): e83381. Nozawa Yuichi, Umemura Takeji, Joshita Satoru, Katsuyama Yoshihiko, Shibata Soichiro, Kimura Takefumi, Morita Susumu, Komatsu Michiharu, Matsumoto Akihiro, Tanaka Eiji, Ota Mas |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: